GSK vaccine chief on $2.1 billion supply deal under U.S. government's Operation Warp Speed

CNBC's Meg Tirrell speaks with GSK Global Vaccines President Roger Connor about the company's and Sanofi's $2.1 billion vaccine deal with the U.S. government.
01:34
Fri, Jul 31 202012:11 PM EDT